autoantibodi Th ribonucleoprotein nucleolar rna particl patient system sclerosi sera consecut new patient system sclerosi ssc scleroderma sera antinuclear antibodi immunofluoresc cell substrat sera dark nucleoli antibodi sera immunoprecipit hela cell extract fifteen sera anti-th+ anti-th antibodi present ssc patient limit cutan involv diffus cutan involv ssc syndrom control connect tissu diseas anti-th patient primari raynaud phenomenon year durat subgroup ssc limit cutan involv anti-th+ patient frequenc puffi finger small bowel involv hypothyroid frequenc arthralgia and/or arthriti cumul surviv rate time onset symptom anti-th- patient year due death pulmonari arteri hypertens primari pulmonari hypertens pulmonari hypertens secondari pulmonari interstiti fibrosi serum anti-th antibodi present patient ssc limit cutan involv primari raynaud phenomenon diseas ssc limit cutan involv antibodi patient risk reduc surviv 